Skip to content

Titan Stabilizer Attachment 45055Recalls & reported problems

Terumo Cardiovascular Systems Corporation

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00699753450554), received between Aug 20, 2019 and Feb 6, 2020 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Fracture” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Fracture1
  • Use of Device Problem1

Patient problems

  • Blood Loss1
  • No Known Impact Or Consequence To Patient1
  • Tissue Damage1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 6, 2020Use of Device Problem; Use of Device Problem

    THE USER FACILITY REPORTED TO TERUMO CARDIOVASCULAR THAT DURING CARDIOPULMONARY BYPASS, WHILE USING THE TITAN STABILIZER, THE RIGHT METAL WISHBONE PART OF THE FOOTPLATE RUBBED A HOLE IN THE HEART. A HEMOSTATIC AGENT WAS USED TO STOP THE BLEEDING. THERE WAS APPROXIMATELY 100 ML OF BLOOD LOSS, THERE WAS MINIMAL DELAY, THE PRODUCT WAS NOT CHANGED OUT, THE SURGERY WAS COMPLETED SUCCESSFULLY.

    Patient problems: Blood Loss; Tissue Damage

    MAUDE report 9679645 ↗
  • MalfunctionAug 20, 2019Fracture; Fracture

    ADDITIONAL INFORMATION RECEIVED THAT NO BLOOD LOSS DURING THE PROCEDURE.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 8910584 ↗

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page